Acarix A/S (ST:ACARIX) — Market Cap & Net Worth
Market Cap & Net Worth: Acarix A/S (ACARIX)
Acarix A/S (ST:ACARIX) has a market capitalization of $27.09 Million (Skr251.75 Million) as of September 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #24196 globally and #459 in its home market, demonstrating a -1.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Acarix A/S's stock price Skr0.21 by its total outstanding shares 1187498248 (1.19 Billion). Also see balance sheet size of Acarix A/S for a full breakdown of the balance sheet.
Acarix A/S Market Cap History: 2016 to 2026
Acarix A/S's market capitalization history from 2016 to 2026. Data shows change from $1.99 Billion to $27.09 Million (-33.31% CAGR). Also see ACARIX cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Acarix A/S is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.31 Billion | 0.18% | #87 of 281 |
Weight: Acarix A/S's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Acarix A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Acarix A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Acarix A/S for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
4.65x
Acarix A/S's market cap is 4.65 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.07 Billion | $638.00K | -$29.78 Million | 1683.87x | N/A |
| 2018 | $390.03 Million | $1.02 Million | -$42.27 Million | 380.89x | N/A |
| 2019 | $162.94 Million | $1.86 Million | -$46.46 Million | 87.74x | N/A |
| 2020 | $151.44 Million | $2.17 Million | -$41.55 Million | 69.79x | N/A |
| 2021 | $111.44 Million | $3.76 Million | -$51.80 Million | 29.64x | N/A |
| 2022 | $36.42 Million | $5.82 Million | -$76.98 Million | 6.26x | N/A |
| 2023 | $24.26 Million | $6.24 Million | -$77.84 Million | 3.89x | N/A |
| 2024 | $32.08 Million | $6.20 Million | -$66.19 Million | 5.17x | N/A |
| 2025 | $34.25 Million | $7.36 Million | -$48.09 Million | 4.65x | N/A |
Competitor Companies of ACARIX by Market Capitalization
Companies near Acarix A/S in the global market cap rankings as of September 19, 2026. Review Acarix A/S (ACARIX) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Acarix A/S by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Acarix A/S Historical Marketcap From 2016 to 2026
Between 2016 and today, Acarix A/S's market cap moved from $1.99 Billion to $ 27.09 Million, with a yearly change of -33.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr27.09 Million | -20.90% |
| 2025 | Skr34.25 Million | +6.77% |
| 2024 | Skr32.08 Million | +32.24% |
| 2023 | Skr24.26 Million | -33.40% |
| 2022 | Skr36.42 Million | -67.32% |
| 2021 | Skr111.44 Million | -26.41% |
| 2020 | Skr151.44 Million | -7.06% |
| 2019 | Skr162.94 Million | -58.22% |
| 2018 | Skr390.03 Million | -63.70% |
| 2017 | Skr1.07 Billion | -46.10% |
| 2016 | Skr1.99 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Acarix A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $27.09 Million USD |
| MoneyControl | $27.09 Million USD |
| MarketWatch | $27.09 Million USD |
| marketcap.company | $27.09 Million USD |
| Reuters | $27.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Acarix A/S
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Au… Read more